The Senate approves during the regular session of this March a project that amends Article 6 of the Law 340-06 on Compromises and Contracts of Goods, Services and Works for the Government to obtain vacancies against the coronavirus (Covid-19) .
This amendment varies one of the articles of the Ley 340-06 of August 18, 2006 in relation to the emergence programs and vacancy themes that have not been presented in the country because there is no indication that a pandemic will occur. .
The change was specifically made in the figure five now established which are the provisions of this provision for the purchase of vacancies in case of pandemic, epidemic or epidemic declared, for its treatment and eradication, in the mark of an exceptional state in its modality of state of emergency, in accordance with the legislative piece.
The Vice-Chancellor of the Dominican Liberation Party (PLD) in the Cámara Alta Senator Senate by Elías Piña, Aris Yván Lorenzo expressed that his party voted in favor of the legislative piece for which he agreed that Gobierno should “think well” akuerdos.
“We’ve been dueling in a way that’s going on in the country, and we’re not going to spare it until we’re done but we’ll apply to the PRM as we have a guy who’s holding the parks that we’re coming to the Gobierno. Now we say that we will approve this when, in October, the governing body celebrates an agreement with AstraZeneca “, said the Legislator during his deliberations.
According to him, the leader of the People’s Force of the People’s province, Dioni Sánchez, took the initiative and implored the Poder Executive to send legislative pieces in order to lead “fast” ways.
The procedure was declared emergence and approved in consecutive lectures. The same was introduced in the works of the Chamber of Deputies by the Cabinet of Public Health.
Approved purchase of Pfizer
The Senado also approved in a single reading the agreement between the Government and the pharmaceutical company Pfizer which consisted of the purchase of 7,999,875 doses of its vaccine against the Covid-19 for a price of 95,998,500 dollars.
A total of 17.5 million of the vacancies for application to the population, need the following. Of this amount, 10 million correspond to AstraZeneca, number AZT1222, which was developed by Oxford University.